Related Articles
Reports from the field
A confident, rising star in Elekta’s linac business, Sonal Bhadane still fretted about what would become of her career when in 2016 she became pregnant with her first child. “I was doing really well at my job, I was on the verge of promotion and everything in my career was on an upward trajectory,” says…
While many Colombian cancer patients experienced long delays in their radiotherapy treatment for prostate and breast cancer due to Covid-19 restrictions, the pandemic has encouraged and accelerated the adoption of hypofractionated protocols that have significantly shortened the patient’s cancer treatment journey. “We started using hypofractionated radiotherapy – 60 Gy in 20 fractions – for our…
In this case study, a newly adopted ultra-hypofractionation scheme was used to treat a male patient diagnosed with early-stage squamous cell carcinoma of the right lung and bronchus. The case was considered medically and technically operable but in light of the ongoing pandemic and since the patient had no underlying health conditions or previous radiation…
For more than half a decade, April 22 has been heralded as Earth Day. It was originally created to raise awareness of the environmental condition of the U.S. and bring the issues into the country’s national agenda. The day is now marked internationally, and this year’s theme is about restoring the earth. To mark the…
Elekta Infinity gives clinicians the technology to deliver precision radiation medicine. June 2020 saw a new dawn of hope and better cancer treatments for patients in and around China’s Zhejiang province with the installation of an Elekta Infinity™ linear accelerator at Zhejiang People’s Hospital. Elekta Infinity brings sophisticated 4D CBCT image guidance and other advanced…
To celebrate the International Day of Women and Girls in Science, we have brought together three female Elekta leaders to discuss their perspectives on gender equality in science-based roles. Here you’ll find out what the current challenges are and what can be done to entice more women to work in this field. Giulia Thompson, PhD,…
March 2020 saw the greatest global shift to homeworking it has ever seen. While businesses rapidly adapted to this situation, what wasn’t immediately obvious was the impact the pandemic would have on employees’ health and wellbeing. Ami Meech, Elekta’s Vice President of HR Americas and Oncology Informatics Solutions, discusses how her team quickly reacted to…
While the rate of growth in the use of Radiation Therapy (RT) in the Asia Pacific region currently exceeds the overall global average growth rate, with a compound annual growth rate of 6.82 percent compared to six percent, globally1, the difference in availability of high-tech cancer care between the ‘East’ and the ‘West’ is still…
As a leading innovator of precision radiation therapy solutions, Elekta is committed to ensuring that every patient has access to the best cancer care possible.
The products and product clinical indications for use described within FOCUS may not have clearance or registration in certain countries. Please consult Elekta in your country for questions concerning a product or clinical use subject. This site may contain information provided by third party sources to Elekta that does not necessarily represent the views of Elekta. Individuals interviewed provided information based on their personal experience and were not compensated for their participation. Accordingly, third party information contained in this site is provided "as is" with no guarantees of completeness, accuracy, usefulness, or timeliness.
© 2022 Elekta | FOCUS Magazine. | Privacy Policy | Cookies
